PTC Therapeutics

Press Releases

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

 
Press Releases
  Date Title and Summary View
Apr 23, 2015
SOUTH PLAINFIELD, N.J., April 23, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: Deutsche Bank 40th Annual Health Care Conference, on Wednesday, May 6th  at 10 a.m. ET at The InterContinental Hotel in Boston, MA Bank of America Mer...
Apr 20, 2015
SOUTH PLAINFIELD, N.J., April 20, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2015 financial results on Monday, May 4, 2015 at 4:30 p.m. (ET) after the closing of the market. The call can be accessed by dialing (877) 303-9216 (dome...
Apr 20, 2015
WASHINGTON, April 20, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Phase 1 clinical data from the company's joint development program with Roche and the SMA Foundation in spinal muscular atrophy (SMA) will be presented at the 2015 American Academy of Neurology 67th Annual Meeting. The late-breaking abstract titled...
Apr 10, 2015
SOUTH PLAINFIELD, N.J., April 10, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 7, 2015 it approved non-statutory stock options to purchase an aggregate of 264,200 shares of its common stock to 25 new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of our ne...
Apr 8, 2015
SOUTH PLAINFIELD, N.J., April 8, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced the appointment of Eric Pauwels as Senior Vice President and General Manager Commercial Operations, Americas. Eric will be responsible for the commercial strategy, organizational build out and launch of Translarna in the US, Canada and Latin...
Mar 19, 2015
SOUTH PLAINFIELD, N.J., March 19, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (Nasdaq: PTCT) today announced a collaboration with the Orphan Disease Center at the Perelman School of Medicine at the University of Pennsylvania focused on translational research for discovering and developing new treatments for orphan disorders. The partnership reflect...
Mar 3, 2015
SOUTH PLAINFIELD, N.J., March 3, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that it will make Translarna available for siblings of patients in certain open label PTC clinical trials for nonsense mutation Duchenne muscular dystrophy (nmDMD). Translarna will be made available to these siblings in advance of commercial...
Feb 27, 2015
SOUTH PLAINFIELD, N.J., Feb. 27, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2014. "2014 was a transformative year for PTC. We are now a growing commercial-stage biopharma company, focused on delivering an...
Feb 16, 2015
SOUTH PLAINFIELD, N.J., Feb. 16, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: Cowen and Company 35th Annual Health Care Conference at The Boston Marriott Copley Place in Boston, MA on Monday, March 2nd. 27th Annual ROTH Conferenc...
Feb 13, 2015
SOUTH PLAINFIELD, N.J., Feb. 13, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to discuss fourth quarter and year end 2014 financial results and provide an update on the company's business and outlook on Friday, February 27, 2015 at 9:00 a.m. (ET) before the opening o...
Page: FirstPrevious
2
... NextLast
= add release to Briefcase
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue